|
ANIX Anixa Biosciences Inc 715446 |
| Income Statement |
|
Revenue
|
form10-q
|
210,000 |
|
Net Income
|
form10-q
|
-12,554,000 |
|
Profit Margin
|
|
-5978.1% |
| Balance Sheet |
|
Current Assets
|
21,362,000 |
|
Assets
|
21,591,000 |
|
Current Liabilities
|
2,500,000 |
|
Liabilities
|
2,703,000 |
|
Equity
|
18,888,000 |
|
Shares Out
|
32,179,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-7,335,000 |
|
Investing Cash Flow
|
4,276,000 |
| Market Analysis |
Market Cap
|
109,410,269 |
|
Price
|
3.08 |
|
BVPS
|
0.59 |
|
PB
|
5.30 |
|
EPS
|
-0.39 |
|
PS
|
0.61 |
|
FCF
|
-3,059,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
| 1/10 |
-0.39 |
|
|
3/12 |
0.14 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANIX documents filed with the SEC.
ANIX Filings
Clear
